Publication: Investigation of early antibiotic use in pediatric patients with acute respiratory infections by high-performance liquid chromatography
Issued Date
2020-01-01
Resource Type
ISSN
10990801
02693879
02693879
DOI
Other identifier(s)
2-s2.0-85075006039
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biomedical Chromatography. Vol.34, No.1 (2020)
Suggested Citation
Pham Van Toi, Khanh V. Doan, Ngo Ngọc Quang Minh, Pham Nguyen Phuong, Menno D. de Jong, H. Rogier van Doorn, Thomas Pouplin Investigation of early antibiotic use in pediatric patients with acute respiratory infections by high-performance liquid chromatography. Biomedical Chromatography. Vol.34, No.1 (2020). doi:10.1002/bmc.4699 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/49562
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Investigation of early antibiotic use in pediatric patients with acute respiratory infections by high-performance liquid chromatography
Abstract
© 2019 Oxford University Clinical Research Unit. Biomedical Chromatography published by John Wiley & Sons Ltd. In this study, we developed and validated two reliable high-performance liquid chromatography (HPLC) methods for the qualitative detection of six oral β-lactams, which are commonly used in pediatric patients with acute respiratory infections (ARIs). Two distinct reverse-phase chromatographic separations of six β-lactams were obtained. Four β-lactams (cefadroxil, cephalexin, cefaclor and cefixime) in urine were separated using a gradient program with a mobile phase consisting of K2HPO4 buffer (20 mm, pH 2.8) and acetonitrile on a LichroCART 250 × 4.6 mm, Purospher STAR C18 end-capped (5 μm) column. Two remained β-lactams (amoxicillin and cefuroxime) were analyzed using a gradient elution with the mobile phase containing K2HPO4 buffer (20 mm, pH 3.0) and acetonitrile on a LichroCart® Purospher Star C8 end-capped column (5 μm, 125 × 4.6 mm). Good linearity within the range of 0.3–30 μg/ml for cefadroxil, cephalexin, cefaclor and cefixime, and 0.2–20 μg/ml for amoxicillin and cefuroxime, was attained. The precisions were <14%. The accuracies ranged from 85.87 to 102.8%. The two validated methods were then applied to determine these six antibiotics in 553 urine samples of pediatric patients with ARIs. As a result, 32.2% were positive with one or more of six tested β-lactams. Cefixime was the most commonly detected agent, accounting for 9.8% of enrolled patients.